Atossa Therapeutics Inc
NASDAQ:ATOS

Watchlist Manager
Atossa Therapeutics Inc Logo
Atossa Therapeutics Inc
NASDAQ:ATOS
Watchlist
Price: 0.6172 USD -2.12% Market Closed
Market Cap: 79.7m USD

Operating Margin
Atossa Therapeutics Inc

0%
Current
0%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-32.9m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Atossa Therapeutics Inc
Glance View

Market Cap
79.7m USD
Industry
Biotechnology

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company is headquartered in Seattle, Washington and currently employs 4 full-time employees. The company went IPO on 2012-11-08. The firm is focused on discovering and developing medicines for breast cancer, other breast conditions and Covid-19. Its Covid-19 drugs under development, including the AT-H201 program, is for severely ill patients on ventilators, and AT-301 COVID-19 is a nasal spray. Its nasal spray formulation AT-301 is being designed to contain ingredients that can potentially block SARS-CoV-2 viral entry gene proteins in nasal epithelial cells by interfering with spike protein activation by host proteases, by masking receptor binding domains via electrostatic mechanisms, and by providing a generalized mucoadhesive epithelial barrier. AT-H201 program is to develop a therapy to improve lung and function like a chemical vaccine. The company is also developing an oral formulation of Endoxifen to reduce mammographic breast density (MBD) and to prevent/reduce gynecomastia in prostate cancer patients starting androgen deprivation therapy.

ATOS Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-32.9m
/
Revenue
0
What is the Operating Margin of Atossa Therapeutics Inc?

Based on Atossa Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top